23

General Information


DRACP ID  DRACP04811

Peptide Name   23

Sequence  YGGFMX

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cαα -dialkylated glycine (Aaa1,1 )

Chiral  L



Physicochemical Information


Formula  C27H33N5O6S

Absent amino acids  ACDEHIKLNPQRSTVW

Common amino acids  G

Mass  75501

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  707

Hydrophobicity  43.33

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  298

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  4017

CancerPPD ID  4018

CancerPPD ID  4019

CancerPPD ID  4020

CancerPPD ID  4021

CancerPPD ID  4022

CancerPPD ID  4023

CancerPPD ID  4024

CancerPPD ID  4025

CancerPPD ID  4026

CancerPPD ID  4027

CancerPPD ID  4028

CancerPPD ID  4029

DRACP is developed by Dr.Zheng's team.